This activity will provide an interactive, patient-focused learning experience on the multidisciplinary management of patients with Fabry disease, a rare multisystemic lysosomal storage disorder resulting from -galactosidase A ( -Gal A) deficiency leading to progressive accumulation of globotriaosylceramide (Gb3) in diverse tissues and organs, including the heart and kidneys. During the symposium you will hear patients personal experiences and be involved in a lively exchange between leading experts and the audience. The clinical journey from diagnosis to treatment will be analyzed, and best practices for multidisciplinary management will be discussed. Furthermore, the experts will review the latest clinical evidence on novel therapies and provide perspectives on treatment strategies.
- Provider:Postgraduate Institute for Medicine
- Activity Link: https://www.cmeuniversity.com/course/disclaimer/124901
- Start Date: 2024-06-07 05:00:00
- End Date: 2024-06-07 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: amicus Therapeutics, Inc. - Amount: 237605.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Internal Medicine